Learn how the TRIDENT Platform is Revolutionizing Drug Discovery for Neurodegenerative Diseases Like Alzheimer's and Parkinson's

In this debut episode of The Catalysts, we explore the cutting-edge, open-source TRIDENT research platform, that’s revolutionizing and de-risking the drug discovery pipeline for neurodegenerative diseases by focusing on "failing faster" — a strategy designed to save time and money, and ultimately lives.

Join Schulich School of Medicine & Dentistry and Robarts Research Institute scientists Dr. Lisa Saksida and Dr. Ravi Menon as they discuss how this innovative approach led by an interdisciplinary team of scientists at Western University is key to finding the most promising drugs and therapies for age-related diseases like Alzheimer's, Parkinson's, and dementia while sparing patients from false hope.